140 related articles for article (PubMed ID: 6329511)
21. Phase II evaluation of pyrazofurin in patients with carcinoma of the lung.
Gralla RJ; Currie VE; Wittes RE; Golbey RB; Young CW
Cancer Treat Rep; 1978 Mar; 62(3):451-2. PubMed ID: 348315
[No Abstract] [Full Text] [Related]
22. Phase II trial of vindesine in patients with small cell lung carcinoma.
Natale RB; Gralla RJ; Wittes RE
Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
[No Abstract] [Full Text] [Related]
23. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
[No Abstract] [Full Text] [Related]
24. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
[No Abstract] [Full Text] [Related]
25. Evaluation of vindesine in patients with refractory small cell lung cancer.
Chang AY; Witte RS; Tormey DC; Ramirez G
Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
[No Abstract] [Full Text] [Related]
26. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
[No Abstract] [Full Text] [Related]
27. Phase II evaluation of triazinate in patients with metastatic lung cancer.
Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
[No Abstract] [Full Text] [Related]
28. Treatment of small cell lung cancer with 6-mercaptopurine: a phase II study.
Hansen SW; Skovsgaard T; Sørensen JB
Cancer Treat Rep; 1985 May; 69(5):555. PubMed ID: 2988775
[No Abstract] [Full Text] [Related]
29. [Results of a phase I-II clinical trial of Emoxyl, a novel antineoplastic anthracycline].
Korman DB; Mikaélian SG; Boronovskaia LE; Maslova IA
Vopr Onkol; 2004; 50(2):202-7. PubMed ID: 15176224
[TBL] [Abstract][Full Text] [Related]
30. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
[No Abstract] [Full Text] [Related]
31. [Amrubicin].
Shimizu T; Takada M; Yana T; Fukuoka M
Nihon Rinsho; 2002 May; 60 Suppl 5():374-7. PubMed ID: 12101692
[No Abstract] [Full Text] [Related]
32. Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer.
Malik ST; Rayner H; Fletcher J; Slevin ML
Cancer Treat Rep; 1987 Dec; 71(12):1291-2. PubMed ID: 2825993
[No Abstract] [Full Text] [Related]
33. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
34. Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomas.
Miller TP; Jones SE; Alberts DS; Mackel C
Invest New Drugs; 1984; 2(1):75-7. PubMed ID: 6469502
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of mitomycin in small cell lung carcinoma.
McHale MS; Einhorn LH
Cancer Treat Rep; 1986 May; 70(5):675. PubMed ID: 3011261
[No Abstract] [Full Text] [Related]
36. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
37. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
[No Abstract] [Full Text] [Related]
39. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
Brown TD; Fleming TR; Shildt RA; Cowan JD
Cancer Treat Rep; 1987 Nov; 71(11):1101-2. PubMed ID: 2824048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]